Transcervical extended mediastinal lymphadenectomy for mediastinal restaging after induction therapy

BACKGROUND: The aim of this study was to retrospectively evaluate long-term survival of stage IIIA-N2 non-small cell lung cancer patients operated after induction chemotherapy or chemoradiotherapy and negative mediastinal restaging with transcervical extended mediastinal lymphadenectomy (TEMLA). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwóźdź, Paweł, Zieliński, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794284/
https://www.ncbi.nlm.nih.gov/pubmed/35118266
http://dx.doi.org/10.21037/med.2019.09.01

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794284/
https://www.ncbi.nlm.nih.gov/pubmed/35118266
http://dx.doi.org/10.21037/med.2019.09.01

Ejemplares similares